Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market

Vicore Pharma Holding AB (6Y4) Cash flow

2 Followers

Vicore Pharma Holding AB Cash Flow

DE:6Y4's free cash flow for Q4 2022 was kr-100.27M. For the 2022 fiscal year, DE:6Y4's free cash flow was decreased by kr-37.75M and operating cash flow was kr-100.27M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
kr -299.92Mkr -299.92Mkr -265.17Mkr -119.94Mkr -87.00Mkr -33.04M
Investing Cash Flow
kr 74.00Mkr 74.00Mkr -7.00Mkr 4.00Mkr -77.15Mkr 15.03M
Financing Cash Flow
kr 187.04Mkr 187.04Mkr 318.18Mkr 176.97Mkr 127.04Mkr 218.68M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
kr 963.73Mkr 256.80Mkr 294.20Mkr 248.62Mkr 187.59Mkr 224.69M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
kr 200.00Mkr 200.00Mkr 336.00Mkr 187.55Mkr 134.83Mkr 232.42M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
kr -302.92Mkr -302.92Mkr -265.17Mkr -122.94Mkr -87.15Mkr -35.04M
Domestic Sales
------
Foreign Sales
------
Currency in SEK

Vicore Pharma Holding AB Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis